MicroRNA-181a functions as an oncomir in gastric cancer by targeting the tumour suppressor gene ATM

Pathology and Oncology Research

Volumn 20, Issue 2, 2014, Pages 381-389

  Zhang, Xiangyang ^a   Nie, Yuqiang ^b   Li, Xiaorong ^c   Wu, Guifu ^c   Huang, Qun ^c   Cao, Jie ^b   Du, Yanlei ^b   Li, Junda ^d   Deng, Ruoyu ^d   Huang, Dongshen ^e   Chen, Baozhi ^f   Li, Shang ^g   Wei, Baojun ^h  

^a Shenzhen Municipal Hospital of TCM   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c The Fourth People's Hospital of Shenzhen   (China)

^d People s Hospital of Longhua   (China)

^e First Hospital of Guangzhou   (China)

^f Second People's Hospital of Lanzhou City   (China)

^g Jiuquan City Health   (China)

^h Department of Pediatrics   (China)

Author keywords

ATM; Gastric cancer; micro RNA; miR 181a; Target gene

Indexed keywords

ATM PROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 181A; UNCLASSIFIED DRUG; ATM PROTEIN, HUMAN; MIRN181 MICRORNA, HUMAN;

APOPTOSIS; ARTICLE; ATM GENE; CANCER CELL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR SUPPRESSOR GENE; BIOLOGY; CELL LINE; CELL MOTION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HEK293 CELL LINE; PHYSIOLOGY; PROCEDURES; STOMACH TUMOR; TUMOR CELL LINE; TUMOR INVASION;

APOPTOSIS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COMPUTATIONAL BIOLOGY; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HEK293 CELLS; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; RNA, MESSENGER; STOMACH NEOPLASMS; TRANSFECTION;

EID: 84898814543     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-013-9707-0     Document Type: Article

References (44)

1. Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24(14):2137-2150
2. Tamura G (2006) Alterations of tumour suppressor and tumour-related genes in the development and progression of gastric cancer. World J Gastroenterol 12(2):192-198
3. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281-297
4. Esquela-Kerscher A, Slack FJ (2006) Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6(4):259-269
5. Calin GA, Dumitru CD, Shimizu M et al (2002) Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99(24):15524-15529
6. Bonci D, Coppola V, Musumeci M et al (2008) The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 14(11):1271-1277
7. Petrocca F, Visone R, Onelli MR et al (2008) E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosisin gastric cancer. Cancer Cell 13(3):272-286
8. Kim YK, Yu J, Han TS et al (2009) Functional links between clustered microRNAs: suppression of cell-cycleinhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res 37(5):1672-1681
9. Ueda T, Volinia S, Okumura H et al (2010) Relation between microRNA expression and progression and prognosis of gastriccancer: a microRNA expression analysis. Lancet Oncol 11(2):136-146
10. Chen CZ, Li L, Lodish HF, Bartel DP (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science (80-) 303(5654):83-86
11. Li QJ, Chau J, Ebert PJ et al (2007) miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129(1):147-161
12. Neilson JR, Zheng GX, Burge CB, Sharp PA (2007) Dynamic regulation of miRNA expression in ordered stages of cellular development. Genes Dev 21(5):578-589
13. Kazenwadel J, Michael MZ, Harvey NL (2010) Prox1 expression is negatively regulated by miR-181 in endothelial cells. Blood 116(13):2395-2401
14. Naguibneva I, Ameyar-Zazoua M, Polesskaya A et al (2006) The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalianmyoblast differentiation. Nat Cell Biol 8(3):278-284
15. Marcucci G, Radmacher MD, Maharry K et al (2008) MicroRNA expression in cytogenetically normal acute myeloid leukemia. N Engl J Med 358(18):1919-1928
16. Pallasch CP, Patz M, Park YJ et al (2009) miRNA deregulation by epigenetic silencing disrupts suppression of the oncogenePLAG1 in chronic lymphocytic leukemia. Blood 114(15):3255-3264
17. Pichiorri F, Suh SS, Ladetto M et al (2008) MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc Natl Acad Sci U S A 105(35):12885-12890
18. Wang Y, Yu Y, Tsuyada A et al (2011) Transforming growth factor-beta regulates the sphere-initiating stem cell-likefeature in breast cancer through miRNA-181 and ATM. Oncogene 30(12):1470-1480
19. Ji J, Yamashita T, Budhu A et al (2009) Identification of microRNA-181 by genome-wide screening as a critical player inEpCAM-positive hepatic cancer stem cells. Hepatology 50(2):472-480
20. Bhattacharya SD, Garrison J, Guo H et al (2010) Micro-RNA-181a regulates osteopontin-dependent metastatic function inhepatocellular cancer cell lines. Surgery 148(2):291-297
21. Yao Y, Suo AL, Li ZF et al (2009) MicroRNA profiling of human gastric cancer. Mol Med Report 2(6):963-970
22. Herzog KH, Chong MJ, Kapsetaki M, Morgan JI, McKinnon PJ (1998) Requirement for ATM in ionizing radiation-induced cell death in the developingcentral nervous system. Science (80-) 280(5366):1089-1091
23. Derheimer FA, Kastan MB (2010) Multiple roles of ATM in monitoring and maintaining DNA integrity. FEBS Lett 584(17):3675-3681
24. Thompson D, Duedal S, Kirner J et al (2005) Cancer risks and mortality in heterozygous ATM mutation carriers. J Natl Cancer Inst 97(11):813-822
25. Mandriota SJ, Buser R, Lesne L et al (2010) Ataxia telangiectasia mutated (ATM) inhibition transforms human mammary glandepithelial cells. J Biol Chem 285(17):13092-13106
26. Kang B, Guo RF, Tan XH, Zhao M, Tang ZB, Lu YY (2008) Expression status of ataxia-telangiectasia-mutated gene correlated with prognosisin advanced gastric cancer. Mutat Res 638(1-2):17-25
27. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402-408
28. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB (2003) Prediction of mammalian microRNA targets. Cell 115(7):787-798
29. Krek A, Grun D, Poy MN et al (2005) Combinatorial microRNA target predictions. Nat Genet 37(5):495-500
30. Betel D, Wilson M, Gabow A, Marks DS, Sander C (2008) The microRNA.org resource: targets and expression. Nucleic Acids Res 36(Database issue):D149-D153
31. Smith PK, Krohn RI, Hermanson GT et al (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150(1):76-85
32. Du Y, Xu Y, Ding L et al (2009) Down-regulation of miR-141 in gastric cancer and its involvement in cell growth. J Gastroenterol 44(6):556-561
33. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435(7043):839-843
34. Tchernitsa O, Kasajima A, Schafer R et al (2010) Systematic evaluation of the miRNA-ome and its downstream effects on mRNA expression identifies gastric cancer progression. J Pathol 222(3):310-319
35. Ciafre SA, Galardi S, Mangiola A et al (2005) Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334(4):1351-1358
36. Gao W, Yu Y, Cao H et al (2010) Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lungcancer is related to clinicopathologic characteristics or patient prognosis. Biomed Pharmacother 64(6):399-408
37. Shin KH, Bae SD, Hong HS, Kim RH, Kang MK, Park NH (2011) miR-181a shows tumour suppressive effect against oral squamous cell carcinomacells by downregulating K-ras. Biochem Biophys Res Commun 404(4):896-902
38. Jazdzewski K, Boguslawska J, Jendrzejewski J et al (2011) Thyroid hormone receptor beta (THRB) is a major target gene for microRNAsderegulated in papillary thyroid carcinoma (PTC). J Clin Endocrinol Metab 96(3):E546-E553
39. Noh H, Hong S, Dong Z, Pan ZK, Jing Q, Huang S (2011) Impaired microRNA processing facilitates breast cancer cell invasion by up regulating urokinase-type plasminogen activator expression. Genes Cancer 2(2):140-150
40. Toller IM, Neelsen KJ, Steger M et al (2011) Carcinogenic bacterial pathogen Helicobacter pylori triggers DNA double-strandbreaks and a DNA damage response in its host cells. Proc Natl Acad Sci U S A 108(36):14944-14949
41. Zhu KQ, Zhang SJ (2003) Involvement of ATM/ATR-p38 MAPK cascade in MNNG induced G1-S arrest. World J Gastroenterol 9(9):2073-2077
42. Lavin MF, Kozlov S (2007) ATM activation and DNA damage response. Cell Cycle 6(8):931-942
43. Bartkova J, Bakkenist CJ, Rajpert-De ME et al (2005) ATM activation in normal human tissues and testicular cancer. Cell Cycle 4(6):838-845
44. Song SY, Kang MR, Yoo NJ, Lee SH (2010) Mutational analysis of mononucleotide repeats in dual specificity tyrosinephosphatase genes in gastric and colon carcinomas with microsatellite instability. APMIS 118(5):389-393